FeelBetter, a machine learning-enabled medication-management platform centered on polypharmacy, introduced it secured $5.9 million in funding led by Firstime Ventures and Shoni Well being Ventures.
Random Forest VC, The Group Ventures, and current FeelBetter investor Triventures additionally participated within the spherical.
The newest spherical brings the corporate’s whole increase to $8 million.
WHAT IT DOES
FeelBetter focuses on the polypharmacy paradigm, the simultaneous use of a number of medication by one affected person for a number of situations. The corporate’s AI-enabled platform analyzes information on a affected person’s well being standing and medical historical past, pharmacology and medical pointers to look at the connections between the totally different sources to enhance a affected person’s remedy routine.
The corporate will use the funds to broaden its attain and advance its platform.
“At a time when traders are particularly selective concerning the sorts of bets they’re taking, this spherical and vote of confidence from the world-class groups at Firstime Ventures, Shoni Well being Ventures, Random Forest VC, Triventures, and The Enterprise Group, in addition to angel traders, validates the necessity for and potential of our pharmaco-clinical intelligence as an answer for the rising, international well being problem posed by suboptimal remedy administration,” Liat Primor, FeelBetter’s CEO and cofounder mentioned in an announcement.
MARKET SNAPSHOT
Polypharmacy has been shown to have an effect on one’s health-related high quality of life negatively, is often seen in older adults and results in a lot of hospital admissions.
Different corporations within the remedy administration area embody Arine, which provides information analytics instruments for remedy administration, and retail big Walmart, which purchased digital remedy administration firm CareZone‘s tech platform, patents and mental property in 2020.
